Lawrence E. Crane

Array ( [id] => 6431307 [patent_doc_number] => 20100152126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'Beta-L-2\'-Deoxy-Nucleosides for the Treatment of Hepatitis B' [patent_app_type] => utility [patent_app_number] => 12/633719 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18175 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152126.pdf [firstpage_image] =>[orig_patent_app_number] => 12633719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6411448 [patent_doc_number] => 20100166670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'USE OF BOSWELLIC ACID AND ITS DERIVATIVES FOR INHIBITING NORMAL AND INCREASED LEUCOCYTIC ELASTASE OR PLASMIN ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/628519 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4864 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166670.pdf [firstpage_image] =>[orig_patent_app_number] => 12628519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6434751 [patent_doc_number] => 20100152434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'Protein Kinase-binding Nucleosides and Associated Methods' [patent_app_type] => utility [patent_app_number] => 12/627898 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23374 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152434.pdf [firstpage_image] =>[orig_patent_app_number] => 12627898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9389343 [patent_doc_number] => 08685941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'Drug composition cytotoxic for pancreatic cancer cells' [patent_app_type] => utility [patent_app_number] => 13/131840 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7323 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13131840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6424190 [patent_doc_number] => 20100168050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'COMPOUNDS HAVING ANTIANGIOGENIC ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/626356 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 3815 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168050.pdf [firstpage_image] =>[orig_patent_app_number] => 12626356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6302215 [patent_doc_number] => 20100068179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Phosphohalohydrins, Process For The Production Thereof And Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/624734 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10018 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068179.pdf [firstpage_image] =>[orig_patent_app_number] => 12624734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7567982 [patent_doc_number] => 20110288045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'WET GRANULATION OF TENOFOVIR, EMTRICITABINE AND EFAVIRENZ' [patent_app_type] => utility [patent_app_number] => 13/129676 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 5140 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288045.pdf [firstpage_image] =>[orig_patent_app_number] => 13129676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778930 [patent_doc_number] => 20120041189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'PENTASACCHARIDE CRISTALLISE, SON PROCEDE D\'OBTENTION ET SON UTILISATION POUR LA PREPARATION D\'IDRAPARINUX' [patent_app_type] => utility [patent_app_number] => 13/130501 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3876 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041189.pdf [firstpage_image] =>[orig_patent_app_number] => 13130501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6589832 [patent_doc_number] => 20100130441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'USE OF VITAMIN B12 FOR TREATMENT OF MUCOSAL LESIONS' [patent_app_type] => utility [patent_app_number] => 12/618379 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8822 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130441.pdf [firstpage_image] =>[orig_patent_app_number] => 12618379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6419652 [patent_doc_number] => 20100150867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'USE OF ALPHA-GLUCOSIDASE INHIBITORS TO TREAT ALPHAVIRUS INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/617676 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 65829 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150867.pdf [firstpage_image] =>[orig_patent_app_number] => 12617676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651842 [patent_doc_number] => 20110301111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'CYCLIC ADENOSINE MONOPHOSPHATES FOR REDUCING THE FORMATION OF ADHESIONS' [patent_app_type] => utility [patent_app_number] => 13/128175 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10073 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301111.pdf [firstpage_image] =>[orig_patent_app_number] => 13128175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574165 [patent_doc_number] => 20110269821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => '5\' AND 2\' BIS-SUBSTITUTED NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM' [patent_app_type] => utility [patent_app_number] => 13/125557 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42929 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269821.pdf [firstpage_image] =>[orig_patent_app_number] => 13125557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039647 [patent_doc_number] => 20110092696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'High performance low residue guar for hydraulic fracturing and other applications' [patent_app_type] => utility [patent_app_number] => 12/589316 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4972 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092696.pdf [firstpage_image] =>[orig_patent_app_number] => 12589316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6614721 [patent_doc_number] => 20100099635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'METHOD FOR TREATING CYSTIC FIBROSIS' [patent_app_type] => utility [patent_app_number] => 12/603506 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5289 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099635.pdf [firstpage_image] =>[orig_patent_app_number] => 12603506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497661 [patent_doc_number] => 20100093990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Nucleotide with an Alpha-Phosphate Mimetic' [patent_app_type] => utility [patent_app_number] => 12/580445 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5604 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093990.pdf [firstpage_image] =>[orig_patent_app_number] => 12580445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10521605 [patent_doc_number] => 09248098 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-02 [patent_title] => 'Treating or preventing pain using spicamycin derivatives' [patent_app_type] => utility [patent_app_number] => 13/122771 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15026 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13122771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4609399 [patent_doc_number] => 07994152 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Method of treating a cancer by administering A 2′,5′-oligoadenylate analog' [patent_app_type] => utility [patent_app_number] => 12/587608 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 85296 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994152.pdf [firstpage_image] =>[orig_patent_app_number] => 12587608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9113301 [patent_doc_number] => 08569476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Method for preparing oligonucleotide' [patent_app_type] => utility [patent_app_number] => 13/003195 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16855 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13003195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7796049 [patent_doc_number] => 08124756 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Method of preparing 5′-amino-linker oligonucleotides derivatives and analogous 5′-labeled-linker oligonucleotides therefrom' [patent_app_type] => utility [patent_app_number] => 12/559666 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4574 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124756.pdf [firstpage_image] =>[orig_patent_app_number] => 12559666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628067 [patent_doc_number] => 20100004192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => '4\'-Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication' [patent_app_type] => utility [patent_app_number] => 12/559186 [patent_app_country] => US [patent_app_date] => 2009-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10555 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004192.pdf [firstpage_image] =>[orig_patent_app_number] => 12559186 [rel_patent_id] =>[rel_patent_doc_number] =>)